Ind-Swift Laboratories share news and announcements
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Last close ₹327.45down ₹17.90 (5.18%)BSE ₹327.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹345.35.
52-week range of traded prices to 23 Oct 2026
₹87.15Low, 31 Dec 2025₹424.75High, 30 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,848 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 49.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 41.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 2.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 4.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,58,24852.8% delivered
Ind-Swift Laboratories share news and announcements
907 announcements, routine notices left out, newest first. Page 18 of 19.
Aug 2009
28 Aug · Board meeting
To consider and approve interalia, among other items, allotment of shares upon part conversion of Zero Coupon Convertible Warrants (SERIES 2008) into equity shares of the holders of the warrants.
Jul 2009
30 Jul · Allotment of Equity Shares
Ind-Swift Laboratories Ltd. has informed the Exchange that the following decision is taken by the Board in its Meeting held on July 30, 2009: The Board has allotted 6,00,000 equity shares upon conversion of 6,00,000 Zero Coupon Convertible warrants (Series 2008) belonging to other Bodies Corporate at a price of Rs.70/- per share.17 Jul · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the first quarter ended June 30, 2009.
Jun 2009
29 Jun · Updates
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of the statement of Appropriations as per Clause 20 of Listing Agreement for the year ended March 31, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jun · Dividend
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on June 29, 2009 have recommended a Dividend of Rs.1/- per share on Equity shares of the Company. Further the Company has informed the Exchange that the Board has allotted 5,00,000 equity shares upon conversion of 5,00,000 Zero Coupon Convertible warrants (Series 2008) belonging to other Bodies Corporate at a price of Rs. 70/- per share.23 Jun · Board meeting
Due to some unavoidable circumstances, the Board Meeting scheduled to be held on June 24, 2009 has been postponed for June 29, 2009 to transact inter-alia among other items the following business: 1) To adopt Annual Audited Accounts for the financial year ended March 31, 2009. 2) To consider declaration of dividend, if any, approved by the Board on the equity shares of the Company.16 Jun · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company have in its meeting held on June 15, 2009, allotted 7,00,000 equity shares of Rs 10/- each at a premium of Rs 60/- per shares to Promoters Group upon the conversion of 7,00,000 Zero Coupon Optionally Convertible Warrants (SERIES 2008).15 Jun · Board meeting
To transact inter-alia among other items the following business : 1) To adopt Annual Audited Accounts for the financial year ended March 31, 2009. 2) To consider declaration of dividend, if any, approved by the Board on the equity shares of the Company.Not held on this date
12 Jun · Board meeting
To consider and approve interalia, among other items , allotment of shares upon part conversion of Zero Coupon Convertible warrants (SERIES 2008) into equity shares of the holders of the warrants.
May 2009
29 May · Allotment of Debentures
Ind-Swift Laboratories Ltd. has informed the Exchange that "The Board has in its meeting held on today i.e. May 28, 2009, allotted 15,00,000 Secured Non Convertible Debentures of Rs 100 each on private placement basis.The debentures will be redeemed in different trenches in next 48 months.
Apr 2009
15 Apr · Results
Ind-Swift Laboratories Ltd. has informed the Exchange that the Company has decided to adopt the audited financial results for the year 2008-09 before June 30, 2009 instead of adopting unaudited quarterly results for the quarter ended March 31, 2009.
Mar 2009
26 Mar · Management
Ind-Swift Laboratories Ltd. has informed the Exchange that pursuant to Clause 30 and Clause 49 (A)(ii) the Listing Agreement, the Board of Directors of the Company in its meeting held on March 24, 2009 have appointed the following as Independent Directors with immediate effect: 1) Mr. H.P.S.Chawla, 2) Mr. N.D.Aggarwal, 3) Mrs.Nirmal Aggarwal.
Jan 2009
9 Jan · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the third quarter ended December 31, 2008.
Nov 2008
4 Nov · Change in registered office
Ind-Swift Laboratories Ltd. has informed the Exchange that as decided by the Board of Directors in its Board meeting held on September 26, 2008 the Company has changed its Registered Office: From: SCO 493-94, Sector 35-C, Chandigarh-1660022. To: SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh - 160101.
Oct 2008
27 Oct · Utilisation of Funds
Ind-Swift Laboratories Ltd. has informed the Exchange vide notes to Accounts in the unaudited financial results for the quarter ended September 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on October 25, 2008) that: "The Company raised a sum of Rs.423.36 lacs during the quarter ended 30.09. 2008 by way of preferential allotment of equity shares. The funds raised were utilized for production facility expansion including capital advances."25 Oct · Meeting
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of Annual General Meeting of the members of the Company held on September 26, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Oct · Board meeting
Meeting on 25 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Sep 2008
29 Sep · Meeting
Ind-Swift Laboratories Ltd. has informed the Exchange regarding the outcome of Annual General Meeting held on September 26, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Sep · Meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Company has fixed the date of closure of Register of Members from September 22, 2008 to September 26, 2008 (both days inclusive) for the purpose of payment of Dividend and Annual General Meeting which is scheduled to be held on September 26, 2008.1 Sep · Allotment of Equity Shares
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company have in its meeting held on August 29, 2008, allotted 3,22,000 equity shares of Rs. 10/- each at a premium of Rs. 60/- per shares to Promoters Group upon the conversion of 3,22,000 Zero Coupon Optionally Convertible Warrants.
Aug 2008
26 Aug · Board meeting
To consider inter-alia among other items allotment of equity shares to promoters Group Company upon conversion of Zero Coupon warrants into equity shares.
Jul 2008
30 Jul · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on July 30, 2008 has approved inter-alia the following: 1) The Board has allotted 3,50,000 equity shares of Rs. 10/- each at a premium of Rs.60/- per share to Promoters Group upon the conversion of 3,50,000 Zero Coupon Optionally Convertible Warrants.17 Jul · Board meeting
To consider inter-alia, Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2008.
Jun 2008
24 Jun · Updates
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of the statement of Appropriations as per Clause 20 of Listing Agreement for the year ended March 31, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Jun · Utilisation of Funds
Ind-Swift Laboratories Ltd. has informed the Exchange vide notes to Accounts in the Audited Financial Results for the year ended March 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on June 19, 2008) that: The Company raised a sum of Rs. 9.28 crores during the year ended March 31, 2008 by way of preferential allotment of Equity shares and Convertible warrants. The issue proceeds have been utilized towards the Expansion of the Existing Manufacturing Facility as per the objects of the Preferential issue.24 Jun · Dividend
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board of Directors at its meeting held on June 19, 2008: (1) The Board has recommended a dividend of 10% on the Equity Shares of the Company. (2) The Board has allotted 5,69,000 equity shares upon conversion of 5,69,000 Zero Coupon Convertible warrants belonging to Promoters group Companies at a price of Rs.70/- per share.11 Jun · Board meeting
To transact inter-alia among other items the following business: 1) To adopt Annual Audited Accounts for the financial year ended March 31, 2008. 2) To Consider declaration of dividend, if any, approved by the Board on the equity shares of the Company. 3) Allotment of equity shares to promoters Group Companies upon conversion of Zero Coupon Warrants into equity shares.
Apr 2008
15 Apr · Results
Ind-Swift Laboratories Ltd. has informed the Exchange that: "The Company has decided to adopt the audited financial results for the year 2007-08 before 30th June, 2008 instead of adopting unaudited quarterly results for the quarter ended 31st March, 2008".2 Apr · Updates
Ind-Swift Laboratories Ltd. has informed the Exchange that w.e.f. today i.e. April 02, 2008, the key positions in the Company's Board has changed as under: 1) Sh. S.R. Mehta has been nominated as the Chairman of the Company. 2) Sh. N.R. Munjal has been nominated as the Vice-Chairman of the Company. 3) Sh. V.K. Mehta has been nominated as the Managing Director of the Company. 4) The post of Joint Managing Director has been abolished."1 Apr · Meeting
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of the proceedings of the Extra Ordinary General Meeting of the Company held on February 29, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
17 Mar · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that: "The Board of Directors of the Company have in its meeting held on today i.e. 14th March, 2008 allotted 25,00,000 Zero Coupon Optionally Convertible Warrants (2008 Series) to Promoter Group Company and other Bodies Corporate at a price of Rs. 70/- per warrant".10 Mar · Board meeting
To consider and approve Allotment of 25,00,000 Zero Coupon Convertible Warrants (2008 Series) to Promoter Group Company and other Bodies Corporate at a price of Rs. 70/- per warrant.
Feb 2008
29 Feb · Meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the shareholders of the Company, in its Extra Ordinary General Meeting held on February 29, 2008 have approved the issue of 25,00,000 Zero Coupon Convertible Warrants (2008 Series) into Equity Shares to Promoter Group Company and other Bodies Corporate at a price of Rs. 70/- per warrant.20 Feb · Meeting
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of the Notice of Extra Ordinary General Meeting of the Company to be held on February 29, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Feb · Change in Board of Directors
Ind-Swift Laboratories Ltd. has informed the Exchange that the Company has restructured its Board as under: 1) Sh. S.R. Mehta has been nominated as the Chairman of the Company. 2) Sh. N.R. Munjal has been nominated as the Vice-Chairman of the Company.3) Sh. V.K. Mehta has been nominated as the Managing Director of the Company. All these changes will come into effect on New Financial year commencing on 01-04-2008. The post of Joint managing Director will be abolished upon the new Designations coming into force.
Jan 2008
29 Jan · Board meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board has in its meeting held today i.e. January 29, 2008 approved inter-alia the following: 1) The Board has allotted 11,96,000 equity shares to Promoters Group upon the conversion of 11,96,000 Zero Coupon Warrants. 2) A fresh issue of 25,00,000 Zero Coupon optionally Convertible Warrants into Equity Shares to Promoters & other Bodies Corporate at a price of Rs. 70/- per warrants. 3) To convene the Extra Ordinary General Meeting of the shareholders of the Company on February 29, 2008 to seek their approval for the above stated preferential issue. 4) Allotted 1,60,000 options to employees under Employee Stock Option plans of the Company.15 Jan · Board meeting
To consider inter-alia, Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2007.
Dec 2007
10 Dec · Miscellaneous
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of Abstract and Memorandum of Interest pursuant to the provisions of Section 302 of the companies Act, 1956. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
6 Nov · Meeting
Ind-Swift Laboratories Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the Company held on September 29, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
30 Oct · Grant of Stock Options
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board in its meeting held on October 29, 2007 have granted 3,00,000 (Three lacs only) Stock Options to the eligible employees of the Company under the Ind-Swift Employees Stock Option Scheme 2006 (ESOP-2006) at a price of Rs.27/- per option. These options will vest with the employees of the Company in a phased manner, over a period of next three years.19 Oct · Board meeting
Meeting on 29 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Sep 2007
25 Sep · Miscellaneous
Ind-Swift Laboratories Ltd. has informed the Exchange that: "the Company has received the USFDA approval for its API manufacturing facility situated at Village Bhagwanpur, Derabassi, Pb."17 Sep · Miscellaneous
Ind-Swift Laboratories Ltd. has informed the Exchange that: "A fire broke out in a section of one of the Bulk Drug facilities of the Company at Derabassi (Punjab) in the Morning of September 15, 2007. The fire was swiftly brought under control with the prompt and active assistance of the fire department and authorities. Other than the affected section of the facility where the fire broke out, all other section of the facilities including all production blocks remained unaffected and continues to operate normally. Cause of the fire is being ascertained."5 Sep · Meeting
Ind-Swift Laboratories Ltd. has informed the Exchange that the Company has fixed the date of closure of Register of Members from September 25, 2007 to September 28, 2007 (both days inclusive) for the purpose of payment of Dividend and Annual General Meeting which is scheduled to be held on September 29, 2007.
Jul 2007
30 Jul · Dividend
Ind-Swift Laboratories Ltd. has informed the Exchange that the Board in its Meeting held on 30th July 2007 has recommended a dividend of 10% on the Equity Shares of the Company.20 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007/Unaudited Financial Results/Dividend/Others”
Apr 2007
24 Apr · Board meeting
Meeting on 30 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Mar 2007
29 Mar · Allotment of shares
Ind-Swift Laboratories Ltd. has informed the Exchange that: "The Board of Directors of the Company have in its meeting held on today i.e. 28th March, 2007 allotted 3,35,000 equity shares upon conversion of 3,35,000 Zero Coupon Convertible warrants belonging to Promoters group Company M/s. Ind-Swift Limited at a price of Rs.70/- per share".23 Mar · Board meeting
To consider and approve interalia, among other items, part allotment of shares upon conversion of Zero Coupon Convertible warrants into equity shares of the holders of warrants.23 Mar · Meeting
Ind-Swift Laboratories Ltd. has submitted the Exchange a copy of proceedings of the Minutes of the Extra-Ordinary General Meeting of the Company held on February 23, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.